Gavestinel Uses, Dosage, Side Effects and more
Highly potent and selective non-competitive antagonist acting at the strychnine-insensitive glycine binding site of the NMDA receptor-channel complex (Kd = 0.8 nM). Gavestinel displays > 1000-fold selectivity over NMDA, AMPA and kainate binding sites and is orally bioavailable and active in vivo.
| Attribute | Details |
|---|---|
| Trade Name | Gavestinel |
| Generic | Gavestinel |
| Gavestinel Other Names | Gavestinel |
| Type | |
| Formula | C18H12Cl2N2O3 |
| Weight | Average: 375.21 Monoisotopic: 374.0224977 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
